QuickView for 8-oxoguanine DNA glycosylase, N-terminal (biogroup)

1. Renal carcinoma RCC-4 cells VHL null or wildtype; effects of exposure to hypoxia
2. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
3. Human primary breast cancer tissue before treatment with gemcitabine, epirubicine and docetaxel
4. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)
5. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)

There were no matches for 8-oxoguanine DNA glycosylase, N-terminal

There were no clinical trials for 8-oxoguanine DNA glycosylase, N-terminal